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GLYCOLIP IDS  OF  THE MOUSE PERITONEAL  
MACROPHAGE 
Alterat ions in Amount  and Surface Exposure o f  Specific Glycol ipid 
Species Occur  in Response to In f lammat ion  and Tumor ic ida l  Act ivat ion 
BY ARTHUR M. MERCURIO,* GERALD A. SCHWARTING,* AND 
PHILLIPS W. ROBBINS* 
From the *Center for Cancer Research, Massachusetts Institute of Technology, 
Cambridge, Massachusetts 02139; andthe *Department ofBiochemistry, E. K. Shriver Center, 
Waltham, Massachusetts 02254 
The macrophage participates in a wide variety of important physiological 
functions, including the recognition and destruction of tumor cells. Since many 
of these functions are mediated by the cell surface, the structural and functional 
characterization f macrophage surface components i an area of considerable 
interest and intense study (I-3). One approach to this study involves analyzing 
alterations in macrophage surface components that occur in response to inflam- 
mation or as a consequence of activation to a tumoricidal state (1-4). Information 
obtained from studying these alterations has proven useful in identifying specific 
components that are involved in some of the specialized surface functions 
characteristic of the inflammatory and the activated macrophage. To date, most 
work in this area has focused on protein components of the macrophage surface, 
particularly on receptor proteins. Although much as been learned from these 
studies, other potentially important components have not been studied in detail. 
Glycolipids constitute one class of surface components for which biochemical 
data are scant. An increasingly large body of evidence indicates that glycolipids 
are important functional components of the cell surface (5); for this reason, it 
seems likely that glycolipids may play key roles in macrophage surface phenom- 
ena, either by themselves, or in concert with other surface components. The 
limited data that do exist on macrophage glycolipids, however, are fragmented 
and contradictory. For example, there are reports that argue both for (6) and 
against (7) the presence on the macrophage surface of asialo GM~, a molecule of 
considerable importance, since it has been implicated as a marker for specific 
types of cytotoxic ells (8). 
In light of the above observations we have carried out a detailed study on the 
major glycolipid constituents of the resident, inflammatory, and tumoricidally 
activated mouse peritoneal macrophage. The results presented in this paper 
demonstrate hat the inflammatory and the activated macrophage are character- 
A. M. M. is a Medical Foundation (Boston, MA) Research Fellow. This work was supported also by 
National Institutes of Health Postdoctoral Fel owship EY05487 (to A. M. M.), and NIH Grants 
CA25532 (to G. A. S.) and CA26712 (P. W. R.). 
Structures ofthe glycolipids referred to in this paper are presented in Table I. 
1 1 14 J. ExP. MED. © The Rockefeller University Press • 0022-1007/84/10/1114/12 $1.00 
Volume 160 October 1984 1114-1125 
 o
n
 N
ovem
ber 1, 2010
jem.rupress.org
D
ow
nloaded from
 
Published October 1, 1984
MERCURIO ET AL. 11 15 
ized by alterations in the chemical amount  and in the surface exposure of  specific 
glycolipid species relative to the resident macrophage. 
Mater ia ls  and  Methods  
Mice. Female C57/BL6 mice obtained from The Jackson Laboratory (Bar Harbor, 
ME) at 7 wk of age were used in all experiments. 
Macrophages. Peritoneal macrophages were obtained by lavage of the peritoneal cavity 
with 10 ml of cold phosphate-buffered saline (PBS; Ca++ and Mg++ free) ~ containing 1
mM Hepes buffer, pH 7.2. Harvested peritoneal cells were centrifuged at 250 g for 10 
rain at 4°C and resuspended in MEM containing 10% heat-inactivated fetal calf serum 
and 2 mM freshly prepared glutamine (normal medium). Aliquots of the peritoneal cell 
suspension (containing -107 macrophages) were plated in 60-mm plastic tissue culture 
plates, and the plates were incubated at 37°C for 4 h. The plates were then washed 
vigorously with PBS to remove the nonadherent cells, and the macrophages were surface 
labeled as described below. 
Resident macrophages were obtained as described above, from untreated mice. ~2-3 
x 106 peritoneal cells were harvested from each mouse, of which 40-50% were macro- 
phages as determined by Wright-Giemsa staining. 
Thioglycollate (TG)-elicited macrophages were obtained from mice that had been 
injected intraperitoneally 4 d before sacrifice with 1.5 ml of a 4% solution of TG broth 
(Difco Laboratories, Inc., Detroit, MI) prepared according to the manufacturer's in truc- 
tions. This procedure yielded 2-3 × 10 v peritoneal cells, of which 80-90% were macro- 
phages. 
In order to obtain bacillus Calmette-Guerin (BCG)-activated macrophages, mice were 
injected with 107 live BCG (Phipps strain 1022; Trudeau Institute, Saranac Lake, NY) 3 
wk before, and subsequently 3 d before, sacrifice. This procedure yielded 5-6 x 106 
peritoneal cells, of which 40-50% were macrophages. 
Cytolysis Assay. All populations of macrophages were tested for their ability to lyse 
P815 cells in an 18-h Na~5~CrO4 (~Cr; New England Nuclear, Boston, MA) release assay 
as described by Russell (9). The assay was carried out in triplicate in 6-mm wells of a 96- 
well microtiter plate containing 5 X 105 adherent macrophages and 5 x 10 ~ labeled P815 
cells. The spontaneous release of 5~Cr from P815 cells during the course of the assay was 
<25% of the total label incorporated. The percent net cytolysis is defined as: [(Released 
cpm in experimental wells - cpm spontaneous release)/(total cpm releasable - cpm 
spontaneous release)] x 100. The cytolysis data are presented in Table II. 
Surface Labeling. Populations of macrophages were surface labeled by the galactose 
oxidase/NaB3H4 method (10). Adherent macrophages were incubated in 2 ml of PBS 
containing 30 U of galactose oxidase (Sigma Chemical Co., St. Louis, MO), for 60 min at 
4°C. The plates were washed with PBS and subsequently 2 ml of PBS containing 2 mCi 
NaB3H4 (New England Nuclear) were added to each plate. The reduction was carried out 
at 4°C for 60 min. In control experiments, the galactose oxidase incubation was omitted. 
Following the NaBSH4 reduction, the plates were washed with PBS and the macrophages 
were scraped off in cold PBS with a Teflon scraper. The macrophage suspension was 
sonicated for 30 s at 4°C with a Branson probe sonicator (model 185; Branson Sonic 
Power Co.; Danbury, CT) set at the lowest setting. An aliquot from each sonicated 
suspension was removed for protein assay performed by the method of Lowry (11), and 
the remaining suspension was centrifuged at 15,000 g for 10 min. The resultant pellet 
was solubilized in 10 ml of chloroform-methanol (2:1) by probe sonication. 
Glycolipid Extraction and Analysis. The chloroform-methanol extracts were dried un- 
der N2, resuspended in distilled water, and desahed on Bond-Elut cartridges (reference 
12; Analytical Chemicals, Harbor City, CA). The desalted glycolipids were chromato- 
graphed on DEAE-Sephadex A-25 (Pharmacia Inc., Piscataway, NJ) to separate neutral 
l Abbreviations used in this paper: BCG, bacillus Calmette-Guerin; StCr, Na2~lCrO4; HPLC, high 
pressure liquid chromatography; HRP, horseradish peroxidase; PBS, phosphate-buffered saline; TG,
thioglycollate; TLC, thin layer chromatography. 
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glycolipids from gangliosides (13). Neutral glycolipids were treated with 0.6 N methanolic 
NaOH for 1 h at room temperature, neutralized with HCI, and desalted. The desalted 
neutral glycolipids were chromatographed on high performance, thin layer chromatog- 
raphy (TLC) plates (E. Merck, Inc., Darmstadt, FRG) in chloroform-methanol-water, 
60:35:8. Gangliosides were also chromatographed on high performance TLC plates in 
chloroform-methanol-water (55:45:10) containing 0.02% CaCI2 as described previously 
(14), and visualized with resorcinol-HCl reagent. TLC plates containing radioactively 
labeled glycolipids were exposed on ultrafilm (LKB, Bromma, Sweden) for 4-14 d at 
room temperature. 
High Pressure Liquid Chromatography. High pressure liquid chromatography (HPLC; 
Waters Associates, Milford, MA) analysis was carried out as described (15) on a 2.1 × 50 
cm Zipax column (E. I. DuPont de Nemours, Inc., Wilmington, DE) with a 13-min 
gradient of 1-20% dioxane in hexane. UV detection at 230 nm was employed. The 
densitometric analysis was performed on the high performance TLC plates using a Zenith 
soft-laser scanning densitometer (Biomed Instruments Inc., Fullerton, CA). 
Gas-Liquid Chromatography. Analysis of the neutral and amino sugar components of
gangliosides was performed by gas-liquid chromatography as described (16). Briefly, 
gangliosides were treated with 0.75 N methanolic HC! extracted in hexane, re-N-acety- 
lated, and analyzed as the Me3Si derivatives on a 3% OV-I column with a temperature 
program of 150-250 °C. 
Sialic acids were analyzed using the same 3% OV-1 column as described (17). Briefly, 
gangliosides were treated with 0.05 N aqueous HCI for 1 h at 80°C and the products 
were converted to the MesSi derivatives. The column was run isothermally at 220°C. 
Sugar ratios were determined empirically and compared with the composition of known 
glycolipids, which were analyzed simultaneously under the same conditions. 
lmmunochromatography. Neutral glycolipids and gangliosides were chromatographed 
on aluminum high performance TLC plates (E. Merck) in chloroform-methanol-water 
(60:35:8), dried, then dipped in 0.05% polyisobutyl methacrylate in hexane as described 
by Brockhaus et al. (18). The plates were then soaked in PBS containing 1% BSA for 2 h 
before exposure to either a rabbit anti-asialo GM1 antibody (19), a rat anti-mouse 
Forssman antigen monoclonal ntibody (20), or to horseradish peroxidase (HRP) conju- 
gated to the ~ subunit of cholera toxin (List Biological Labs, Campbell, CA). HRP- 
conjugated anti-rabbit or anti-rat immunoglobulins (Accurate Chemical & Scientific Corp., 
Westbury, NY) were used as second-step antibodies. The plates were developed with 33 
mM 4-chloro-l-naphthol in Tris buffer containing 2% methanol and 0.25% H~O2. 
Results 
Populations of adherent resident, inflammatory, and BCG-activated mouse 
peritoneal macrophages were surface labeled by the galactose oxidase/NaB3H4 
method (10), and glycolipids derived from these macrophages were resolved into 
individual species by high performance TLC and, in some cases, by HPLC. 
Comparisons were made among the macrophage populations on the basis of 
types of glycolipid species present, the relative amounts of these glycolipids 
(normalized to total cellular protein), and their accessibility to labeling. 
In contrast o the standard galactose oxidase/NaB3H4 protocol (10), the entire 
procedure was carried out at 4°C to minimize the effects of membrane recycling 
on the surface labeling pattern (21). No labeling of glycolipids was evident in 
any of our experiments in the absence of galactose oxidase treatment, establishing 
that the labeling observed in the presence of galactose oxidase is specifically in 
carbohydrate. In addition, no differences in the surface labeling patterns were 
observed for any given population of macrophages plated at different densities. 
Of  the three populations of macrophages, only BCG-activated macrophages are 
capable of lysing P815 cells during an 18-h 51Cr- release assay (Table II). 
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Neutral Glycolipids. Analyses of the neutral g ycolipid fraction obtained from 
the three macrophage populations (Fig. 1 A) indicate that CMH, CDH, and asialo 
GM1 are the major constituents ( ee Table I for structures). The neutral glyco- 
lipids are present in very small amounts (~6.6 #g neutral glycolipid/mg protein) 
and, as a result, could not be visualized easily b TLC. They are identifiable by 
HPLC, however, and the data indicate that the amount of CMH present is 
considerably greater than that of either CDH or asialo GMI in all of the 
macrophage populations. The HPLC analyses also indicate that the TG-elicited 
macrophage contains more of these glycolipids than either the resident or BCG- 
TABLE I 
Structures of Glycolipids 
Galactosy lceramide  (CMH} Gal -Cer  
G lucosy lceramide  (CMH) Glc -Cer  
Lactosy lceramida  (CDH) Ga l (~ I -~)G lc -Csr  
G lobot r taosy lceramlde  (CTH) Ga l (a - l -4 )Ga l (~ l -4 )G lc -Cer  
G lobotet raoa~leeramide  (Globoa£de) GaXN&¢t~l -3 )Ga l la l -~)Ga l (~ l -4 )G le -Cer  
Gangl iotetraosylceramid@ (As ia lo  GM1) Ga l (~ I -3 )Ga lN&e(~I -q )Ga I (~ I -4 )G Ie -Cor  
Forssman GalNAe(a l -3 )Ga lN~c(~I -3 )  Ga l (~ l -Ga l (01-q)G lc -Car  
4) 
GH3 Ga l (~ I -4 )G Ic -Cer  
3 
2 a 
NeuAe 
GM2 Ga IHAc|~1-~)Ga1(~1-4)G lc -Car  
3 
2 a 
NeuAc 
GMI Ga l (~ I -3 )Ga lNAc(~I -~)Ga l [~ I -4 )G le -Cer  
3 
2 a 
NeuAe 
GDIa  Gal (~-3 JGa iNAc(~1-~)Ga l [~1-~)G1c-Cer  
3 3 
2 a 2 a 
NauAe NeuAc 
GDIb Ga l{~J -3 )Ga lNAc(~1-~)Ga l (~1-~)G lc -Cer  
3 
2 a 
NaUAC(G2-8)NaUAC 
* Abbreviations: Gal, I>galactose; Glc, D-glucose; GalNAc, N-acetyl-l~galactosamine; GleNAc, N-acetyl-o-glucosamine; Cer (ceramide), 
N-acylspbingosine. 
TABLE II 
Cytolysis of ~tCr-labeled P815 Targets by Macrophage Populations* 
Macrophage populations t Net cytolysis I 
% 
Resident 0 
TG-elicited 0 
BCG-activated 20.1 (_ 1.8)-56.0 (+ 6.0) 
* 18-h assay performed as described in Materials and Methods. 
* Macrophage populations were obtained as described in Materials and 
Methods. 
0 Values reported are the lowest and highest cytolysis values (+SD) ob- 
tained for each macrophage population in several experiments. 
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FIGURE 1. Chromatograms of neutral glycolipids derived from mouse peritoneal macro- 
phages. (A) HPLC of neutral glycolipids derived from resident, BCG-activated, and TG-elicited 
macrophages and detected by UV at 205 nm as the perbenzoyl derivates. The standard peaks 
are identified as the derivatives of: (1) globotriaosylceramide (CTH); (2) globotetraosylceram- 
ide (globoside); and (3) gangliotetraosylceramide (asialo GM 0. The peaks at 6 and 10 min 
correspond with ceramide monohexoside (CMH) and lactosylceramide (CDH), respectively. 
For each sample, the equivalent of 150 ~tg of cellular protein was analyzed. (B) Autoradiogram 
of a high performance thin layer chromatogram of neutral glycolipids derived from resident, 
BCG-activated, and TG-elicited macrophages surface labeled by the galactose oxidase/NaBSH4 
method. Each lane represents he equivalent of 200 ~tg of cellular protein. 
activated macrophage: the latter two populations contain approximately equal 
amounts of these glycolipids. 
Asialo GMz is the predominant eutral glycolipid labeled on the macrophage 
surface as shown in Fig. 1 B. Asialo GM~ is resolved into two distinct species by 
TLC (Fig. 1 B), and we have confirmed that both of these species are bona fide 
asialo GM1 by their ability to bind a rabbit anti-asialo GM1 antibody (19) as shown 
by immunochromatograpby using an HRP-conjugated second antibody (Fig. 
2A). Similar experiments with an anti-Forssman monoclonal antibody (20) indi- 
cate the presence of Forssman antigen in TG-elicited macrophages (Fig. 2B). 
Forssman antigen cannot be detected in TG-elicited macrophages by chemical 
means, including HPLC, presumably because it is present in very small amounts. 
Other macrophage populations have not been examined for the presence of 
Forssman antigen. 
Although we consistently observed labeling of asialo GM1 on the surface of 
BCG-activated macrophages, we have never observed its labeling on the surface 
of resident macrophages (Fig. 1 B) even though, as stated above, asialo GM1 is 
present in resident macrophages in amounts equivalent to that found in BCG- 
activated macrophages. The intensity of labeling of asialo GM~ on the surface of 
TG-elicited macrophages is consistent with the increased amount of this glyco- 
lipid in these cells (Fig. 1), and it is greater than the labeling of asialo GM1 on 
the surface of BCG-activated macrophages. 
Gangliosides. Resorcinol staining of macrophage gangliosides separated by 
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FIGURE 2. Immunochromatography of neutral glycolipids derived from TG-elicited macro- 
phages. (A) High performance, thin layer chromatogram of neutral glycolipids from TG- 
elicited macrophages (TG) and from a standard mixture of brain glycolipids (S)exposed to a 
rabbit anti-asialo GMI antibody (19) and visualized with an HRP-conjugated anti-rabbit 
immunoglobulin as a second antibody. (/3) High performance, thin layer chromatogram 
identical to A but exposed to M1/87, a rat anti-mouse monoclonal antibody specific for 
Forssman antigen (20) and HRP-conjugated anti-rat immunoglobulin. The positions of glo- 
boside, Forssman antigen, and asialo GM~ in the standard mixture a  indicated. 
TLC (Fig. 3A) indicates that GM~ is the predominant ganglioside in all three 
macrophage populations. The amount of ganglioside material in the mouse 
macrophage (~ 10 #g/mg total cellular protein) is considerably greater than the 
amount of neutral glycolipid. 
Three distinct molecular species have been ascribed to GMI in our TLC 
separations (denoted 1, 2, and 3 in Fig. 3). The identification of  these three 
species as GM~ is based on their co-migration with standard brain GMI (which is 
comprised of only one species) and, more importantly, on their ability to bind 
the beta subunit of  cholera toxin conjugated to HRP (Fig. 4). The beta subunit 
of cholera toxin has a specific and high affinity for GM1 (22). Comparison of the 
resorcinol staining pattern and the cholera toxin-HRP binding pattern indicates 
that only two species of GMI are present in resident macrophages ( pecies 2 and 
3). In contrast, three distinct species are present in TG-elicited macrophages. 
BCG-activated macrophages also appear to contain these three GM1 species, as 
indicated primarily by the surface labeling data (see below); the ability of the 
first GM1 species in BCG-activated macrophages to bind cholera toxin-HRP, 
however, is considerably reduced compared with its ability in TG-elicited mac- 
rophages (Fig. 4). It is interesting to note that there is a fourth molecular species 
that migrates with a mobility similar to GM1 in all three macrophage populations, 
but that does not bind cholera toxin-HRP. The identity of the molecular species 
migrating slower than GM~ in the region of GDla and GDIb has not been 
determined. 
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FIGURE 3. High performance, thin layer chromatograms of gangliosides derived from mouse 
peritoneal macrophages surface labeled by the galactose oxidase/NaBSH4 method. Each lane 
represents the equivalent of 300 #g of cellular protein. (A) Detection of gangliosides by 
resorcinoI-HCI staining. (B) Autoradiogram of the same chromatogram exposed for 7 d. Lanes 
1 and 5 are derived from resident macrophages; lanes 2 and 6 are derived from BCG-activated 
macrophages; lanes 3 and 7 are derived from TG-elicited macrophages; lane 4 contains 
standard gangliosides derived from bovine brain and these are indicated in the margin. 
Individual ganglioside species in the GMI region are numbered 1-4. 
FIGURE 4. Immunochromatography of gangliosides derived from mouse peritoneal macro- 
phages. Gangiiosides from resident, BCG-activated, and TG-elicited macrophages were sepa- 
rated by high performance, thin layer chromatography and the chromatogram was exposed 
to the beta subunit of cholera toxin (choleragenoid) conjugated to HRP. The HRP was 
visualized by carrying out the peroxidase reaction. The individual GM1 species corresponding 
to those in Figs. 3 and 5 are indicated at the right. 
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To obtain additional structural information on the GM~ species present in TG- 
elicited macrophages, the region of the TLC plate containing these species was 
scraped and subjected to additional studies. Gas-liquid chromatographic analysis 
indicates that they contain galactose, glucose, and N-acetylgalactosamine  a 
ratio of 2:1:1, substantiating the presence of GM1 (see Table I). Analysis of the 
neuraminic acid content of these GM1 species indicates that they contain an 
approximately equal mixture of N-acetyl and N-glycolyl neuraminic acid. Such 
differences in neuraminic acid, as well as differences in ceramide structure, could 
contribute to the presence of distinct GM~ species. 
Interestingly, alterations in the relative chemical amounts of the GMI species 
exist among the macrophage populations (Fig. 3A). As indicated above, one of 
the species appears to be totally absent from resident macrophages and it is 
present only in TG-elicited and BCG-activated macrophages; moreover, this first 
GMI species is more abundant in TG-elicited macrophages than in BCG-macro- 
phages. The other major change involves the third GM~ species. This species is 
more abundant in TG-elicited macrophages than in either resident or BCG- 
activated macrophages. These alterations are readily apparent in the densito- 
metric scan of the corresponding TLC plate (Fig. 5). 
The galactose oxidase/NaB3H4 labeling of surface gangliosides (Fig. 3B) indi- 
cates that the three species of GMt are the predominant gangliosides labeled on 
the macrophage surface, and also points out interesting differences between the 
relative amounts of these species and their accessibility to galactose oxidase/ 
NaB~H4 labeling. The differences are visualized easily by comparing the densi- 
' j 
~.. 
RES 
2 
\ 
BCG 
I 2 
TG 
FIGURE 5. Densitometric scan of the GMI region of the high performance, thin layer 
chromatogram shown in Fig. 3. (A) Scan of the resorcinol-HCI stained chromatogram (Fig. 
3A). (B) Scan of the autoradiogram of this chromatogram (Fig. 3B). The numbered peaks 
correspond to the numbered GM, species in Fig. 3. The densitometric analysis was performed 
using a Zenith soft-laser densitometer. 
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tometric scans of the resorcinol stain and autoradiogram of the same TLC plate 
(Fig. 5). A striking contrast is observed in the labeling of the third GM1 species 
between TG-elicited and BCG-activated macrophages. This GM1 species is la- 
beled intensely on the surface of BCG-activated macrophages and only faintly 
on TG-elicited macrophages ven though, as stated above, it is more abundant 
in TG-elicited macrophages. Both of the GM1 species present in resident mac- 
rophages are labeled intensely on the surface. No labeling of the first GM1 species 
is evident on resident macrophages, providing additional evidence that it is 
absent from this population of macrophages. The first GM~ species is labeled on 
the surface of BCG-activated macrophages, even though it is barely detectable 
by resorcinol staining and cholera toxin binding. It is labeled prominently on the 
surface of TG-elicited macrophages. 
Discussion 
An understanding of the mechanism by which macrophages acquire the 
capacity for the recognition and subsequent lysis of tumor cells is one of the key 
unresolved problems in macrophage cell biology. Recent studies have focused, 
in part, on alterations in surface proteins that accompany tumoricidal activation 
and on their potential functional significance (1-4). In contrast, before our work, 
little information that dealt with macrophage surface carbohydrates was available. 
The results presented in this paper are concerned with a major class of surface 
carbohydrates, the glycolipids. Comparison of populations of resident, TG- 
elicited, and tumoricidally activated macrophages indicates ignificant differences 
in the chemical amount and accessibility to galactose oxidase/NaBaH4 labeling 
of their glycolipid constituents. Therefore, we conclude that a chemical and 
spatial reorganization of macrophage surface glycolipids occurs in response to 
tumoricidal activation and inflammation. 
It is well established that the accessibility of surface glycolipids to external 
probes provides an indication of their degree of surface exposure (5, 23). The 
two most widely used probes for measuring lycolipid exposure are vectorial 
galactose oxidase/NaB3H4 labeling and antibody binding. Galactose oxidase/ 
NaB3H4 labeling was the method of choice in this study, since it detects abroader 
spectrum of glycolipids and it is not limited by technical considerations such as 
antigen concentration. In the present work, we minimized the possibility of 
labeling internal membrane compartments byperforming the labeling procedure 
at 4 °C (21). It is worth mentioning, however, that we did observe similar results 
in the experiments in which the macrophages were labeled at 37°C. 
The biochemical basis for differences in glycolipid exposure has not been 
elucidated in detail for any system, although proteins (5) and other carbohydrates 
(24) have been implicated as factors influencing the degree of glycolipid expo- 
sure. Differences in the glycolipid structure itself may also affect exposure (23). 
The alterations in surface xposure observed in the present s udy do not appear 
to result from a nonspecific increase in accessibility to galactose oxidase/NaBaH4 
labeling in TG-elicited and tumoricidally activated macrophages. This is evi- 
denced by the observation that GMx is labeled on the surface of resident 
macrophages while asialo GM1, although present, is not accessible to labeling on 
these macrophages. Rather, our results provide evidence for a selective xposure 
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of specific glycolipids. The differences in exposure may relate to alterations in 
surface polypeptides (25) and fatty acids (26, 27) that have been reported to 
occur in activated macrophages. 
An intriguing observation is that TG-elicited and tumoricidally activated 
macrophages contain a third GMa species, or subtype, apparently not present in 
resident macrophages. The possible functional implications of this additional 
subtype are unclear. We are currently in the process of obtaining additional 
structural information on these individual GM1 species, which should provide 
insight into the biochemical basis of the alterations in glycolipid composition. 
The biochemical nd immunological data presented in this study demonstrate 
convincingly that asialo GM~ is present in the mouse peritoneal macrophage, and 
that it is accessible to labeling on the surface of TG-elicited and tumoricidally 
activated macrophages but not on resident macrophages. Asialo GM1 has received 
considerable attention as a surface marker, particularly since it has been reported 
to be a selective marker for natural killer cells (8). The presence of asialo GM~ 
on the surface of macrophages has been a matter of dispute (e.g., 6, 7), and no 
data before this study had been available on its surface distribution among 
populations of macrophages differing in their state of activation. One inherent 
problem in many of these studies is that their conclusions have been derived 
largely on the basis of immunological data, using antibodies that have not been 
adequately characterized. The anti-asialo GMl antibody used in our work has 
been well characterized and is known to react with asialo GM~ on the surface of 
mouse lymphocytes (19). 
In recent studies on macrophage activation, a major strategy undertaken has 
involved the identification of components hat distinguish the surfaces of inflam- 
matory and tumoricidally activated macrophages from resident macrophages (1- 
4). Our results suggest that surface differences among macrophage populations 
need not necessarily be qualitative, but may also reside in the spatial organization 
of surface components. This possibility is supported by the differences in gan- 
glioside exposure observed between BCG-activated and TG-elicited macro- 
phages, as well as by the selective xposure of asialo GM1 on the surface of BCG- 
activated and TG-elicited macrophages. Moreover, as will be reported elsewhere 
(Mercurio, A. M., G. A. Schwarting, and P. W. Robbins, manuscript in prepa- 
ration) a spatial reorganization of surface glycolipids appears to accompany the 
in vitro acquisition of tumoricidal capacity by TG-elicited macrophages in the 
presence of gamma interferon and LPS. It is interesting to speculate that a spatial 
reorganization of surface components could serve to increase the accessibility of 
those macrophage components required for effective tumor cell interactions. 
In summary, the results presented in this paper demonstrate hat the glycolipid 
constitutents of the mouse peritoneal macrophage are dynamic structures exhib- 
iting specific chemical and spatial alterations in response to inflammation and 
tumoricidai activation. Moreover, taken together with our other recent work on 
protein-bound carbohydrates (28, 29), ~ the present data substantiate he hypoth- 
2 Mercurio, A. M., and P. W. Robbins. 1984. Marked structural alterations in a specific class of 
protein-bound surface carbohydrates--the lactosaminoglycans--occur in response to inflammation 
and tumoricidal activation of mouse peritoneal macrophages. Manuscript submitted for publication. 
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esis that macrophage activation is accompanied by widespread alterations in 
surface carbohydrates. 
Summary  
We have characterized the major glycolipid constituents of the mouse perito- 
neal macrophage, and have demonstrated that alterations in the amount and in 
the accessibility of specific glycolipid species to galactose oxidase/NaBSH4 label- 
ing, an indicator of glycolipid surface exposure, occur in response to inflamma- 
tion and as a consequence of activation to a tumoricidal state. The key findings 
are: (a) Asiaio GM1, a major neutral glycolipid constituent of all macrophage 
populations examined, is accessible to galactose oxidase/NaBSH4 labeling on the 
surface of TG-elicited and BCG-activated macrophages but not on resident 
macrophages; (b) GM~ is the predominant ganglioside constituent of the mouse 
macrophage. Resident macrophages contain two distinct GM~ species, as deter- 
mined by cholera toxin binding, while TG-elicited and BCG-activated macro- 
phages contain an additional GM~ species. Differences in the relative amounts of 
these GM1 species, as well as in their accessibility to galactose oxidase/NaB~H4 
labeling, exist among the macrophage populations. These observations suggest 
that both a chemical and spatial reorganization of surface glycolipids occurs in 
response to inflammation and tumoricidal activation. 
We thank Dr. Maria Kukuruzinska for critical comments on the manuscript, Anna 
Gajewski for expert echnical assistance, and Devon Young for secretarial ssistance. 
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